Putting patients first?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N E Mischler.
Explore the source record for details and available documents.
Since the first published report of mortality in cystic fibrosis in 1969, the median survival among cystic fibrosis patients has risen from 14 to 31 years. The reasons for this improved survival are complex and include earlier diagnosis; improved control of pulmonary infection; aggressive nutritional intervention; and enhanced monitoring of patients in peer-reviewed, accredited centers for cystic fibrosis care, teaching, and research. Emphasis on the importance of research on changing and improved treatment has been effectively communicated to patients and families. As a result, a group of highly educated medical consumers has been created. During the last decade, another focus of rapid change has appeared, that of cost containment in the medical profession, creating the field of managed care. Practicing medical professionals perceive the need for reduction in excessive spending in medicine and have taken a variety of approaches to balance better the value and cost of medical care while maintaining superb quality. Physicians and consumers continue to have concerns about the potential negative impact of managed care on a relatively rare, specialized, and chronic illness such as cystic fibrosis if managed care concepts are applied without proper understanding of the disease. A great concern is that managed care in cystic fibrosis may cause reversal of trends in improved quality and length of survival. The increased length of survival places an increasing demand on the already stressed system of health care financing. Understanding the changing area of managed care is therefore of paramount importance to clinicians involved in cystic fibrosis care. The Cystic Fibrosis Foundation has presented symposia on managed care at each of the last three annual meetings, including the North American Cystic Fibrosis Meeting, October 1996. The following issues were addressed by speakers and panel discussants, with portions excerpted for this review: trends in managed care, measures and guidelines useful in managed care, Medicaid managed care and cystic fibrosis, and practical aspects of using pathways in caring for patients with cystic fibrosis.
What are the economic elements for success in managed care? Although they are quite simple, achieving them can be difficult. The criteria for success in the fee-for-service medical delivery system, generally characterized as "see more--do more--get more," are no longer valid for delivering care in a managed care system. This article identifies the economic elements for success in managed care, and offers a disciplined approach to achieving them, combining both actuarial and clinical expertise.
As part of its strategic plan, Physician Plus Insurance Corp. (PPIC), an 80,000-enrollee, provider-owned, network-model, prepaid insurance plan has targeted improvement in enrollee and community health. Health promotion/disease prevention (HP/DP) guidelines were developed as one tool to promote health screening and to close identified gaps between desired and actual rates of health screening. Additional efforts within the health plan have focused on identifying barriers to health screening and on identifying and implementing solutions to overcome these barriers. Opportunities in health screening are identified from in-house data: mammography, Pap smear, cholesterol screening, immunization rates, and the like. Note that these screening topics are among those that the Health Plan Employer Data and Information Set (HEDIS) has selected. This article will describe the processes to develop HP/DP guidelines, obtain provider participation, obtain buy-in from providers, and educate enrollees and employers. It will also show the results that have been obtained in the form of HP/DP Guidelines and outcomes measures.
There are great gaps in the well-being of patients and communities. But there are numerous practice and community tools and opportunities that can successfully close these gaps. The health care professional is an often overlooked and underutilized resource and leader to positively influence the health of the community and patient. Physicians and health care professionals are in the health care field to maintain and increase the well-being of their patients and communities through disease prevention and health promotion at the practice level. This article argues that combining a community-level public health approach with the traditional practice level approach is more likely to achieve well-being for both individual patients and the community.
In a phase II study dibromodulcitol (DBD), an alpha-omega dibrominated hexitol, was used to treat 99 previously treated patients with colon, rectal, kidney, and other tumors. Six patients were ineligible and 10 patients were nonevaluable for response. Aside from thrombocytopenia toxicity was moderate. Twenty-three patients had platelet nadirs of less than 50,000/mm3 and there were three thrombocytopenic-associated drug deaths. One of 21 rectal and 1 of 13 kidney cancer patients entered a remission. All but seven patients had received previous treatment with one or more cytotoxic agents. Previously treated patients with colorectal and kidney cancer appear to be resistant to DBD.
Malignant mesothelioma presenting in the pleura and peritoneum is described in a middle-aged man. The patient lacked significant asbestos exposure which is not unexpected from both the clinical literature and animal inhalation tumor data. Computerized axial tomographic correlation is provided. Partial remission was achieved with the administration of adriamycin and DTIC.
Synovial sarcoma is a rare neoplasm that uncommonly arises in the neck. Fourteen years after facial and neck radiation therapy for acne, synovial sarcoma of the neck developed in a young man. Possible radiation-induced benign and malignant neoplasms that arise in the head and neck region, either of thyroid or extrathyroid origin, remain a continuing medical problem.
As physicians and medical centers move into a changing reimbursement era, it is valuable for physician executives to have tools to help physicians understand the relationships among costs, revenues, and utilization. These relationships differ within the fee-for-service, prepaid, and managed fee-for-service revenue models. This article describes these different revenue models and highlights the benefits and issues associated with each model.
Explore the source record for details and available documents.